Your Article Summary
See Latest ArticlesGSK Signs Deal with Concert Pharma to the Tune of $1 Billion
PharmExec, 06/04/09
A potentially powerful new technology found a big-pharma sponsor this week as GlaxoSmithKline announced on Tuesday that it had signed a collaboration agreement with three-year-old biotech firm Concert Pharmaceuticals. The deal provides Concert with $35 million up-front and up to a billion dollars in milestone payments. Under the terms of the agreement, Concert will develop three of its compounds through agreed-upon clinical trials, at which point GSK will have an option to obtain an exclusive worldwide license to them.
Today in M&A/Partnerships...keeping you current
Receive free subspecialty "5-minute updates" via email
Bayer CropScience and FuturaGene sign license agreement for drought tolerance technology in cotton
BayNews International, 12/04/09
Sanofi-aventis enters into an Exclusive Global Licensing Agreement with The Rockefeller University
Sanofi-aventis, 12/04/09
Watson Receives FTC Clearance for Arrow Acquisition
Watson Pharmaceuticals, 12/03/09